SunCoast Blood Bank
1760 Mound St
Sarasota FL 34236

SunCoast Blood Bank provides a reliable supply of quality blood products and services to hospitals and health centers in need.*

*Due to multiple services, research and treatment programs and service areas added since this mission statement was written, it is in the process of being revised. 

CEO/Executive Director Mr. Scott M. Bush
Board Chair Admiral, Ret. Steve Branham
Board Chair Affiliation retired
General Info
Organization DBA
Suncoast Communities Blood Bank
DBA SunCoast Blood Bank
Former Names
Lower West Coast Blood Bank
Sarasota Community Blood Bank
Suncoast Communities Blood Bank
Tax Exempt Status Public Supported Charity
Incorporation Year 1969
Awarded competitive grant from Community Foundation in the last 5 years? Yes
State Charitable Solicitations Permit Yes May 2018
State Registration Yes Dec 2018
Financial Summary
IRS Letter of Determination
IRS Determination LetterView
Other Documents
FDA Blood Bank RegistrationView
AABB AccredidationView
CAP AccredidationView
AABB Certificate for Accrediation of Donor Center ActivitiesView
AABB Accrediation for Transfusion ActivitiesView
State of Florida Clinical Laboratory LicenseView
FDA Blood Bank RegistrationView
FDA Registration for Collection and Distribution For Human Cells, Tissues, and Cellular and Tissue-Based ProductsView
Impact Statement


SunCoast Blood Bank was named Nonprofit of the Year by the Sarasota Chamber of Commerce.

During its last two audits, SunCoast was commended for its sound financial practices, citing .92 cents of every dollar go directly to its mission.

SunCoast worked with its network of affiliate blood banks organizing Hurricane Harvey relief efforts, including using the resources of the US Navy, to provide hundreds of units of blood to the affected regions of Texas. Two weeks later SunCoast, with the support of its community partners ensured no patient waited for or went without blood products when Hurricane Irma struck our community.

SunCoast implemented its new Blood Establishment Computer System (BECS), which was an 18-month process.  The BECS is the central nerve system of a blood bank as it traces every touch point of the blood product from the time a donor presents to the time the unit is transfused. This BECS eliminated SunCoast's 10-year-old paper-based system making its record keeping virtually error proof. SunCoast received a $150,000 grant from Sarasota Memorial Healthcare Foundation for the system.

The shelf life of platelets is five days. SunCoast was the first blood bank in the country to implement the Verax Biomedical 7-day platelet dating to extend platelet shelf life. Platelets are the most vital products collected by any blood bank and are critical for the treatment of cancer patients and those with bleeding disorders. 


After conducting a year-long assessment of needs, the board voted to expand and move the main campus from its Mound Street location. Many factors were taken into consideration including the addition of SMH's Level 2 Trauma Center, the new SMH campus planned for Venice and the addition of the SMH destination cancer treatment center. SunCoast must begin to prepare now, as these factors alone will result in a substantial increase blood product usage. Hurricane Irma was clear indicator that the Mound facility sits barely above sea level, directly adjacent to Hudson Bayou. SunCoast has outgrown its current facility and lacks enough space for administrative and production staff and the equipment required to produce and store blood products. Its operations are spread out among several leased facilities, impacting its efficiency. Consolidating its operations under one roof will be more cost effective and improve productivity. The board has invited John Elbare of Florida Philanthropic Advisors, to conduct a workshop on February 3, 2018 to determine the next steps and develop a timeline.

Retain space within a few blocks radius of the Mound Street headquarters for a donor center.  The Mound Street donor center is the highest producing of its five brick and mortar locations, averaging 30-50 donors per day. Experience taught SunCoast that moving an established donor center even 2 miles, drops the donor base from that facility dramatically.  It learned this when it lost its long-term lease in Nokomis and moved the donor center two miles south on US 41.  Ideally, it will locate an adequate space for 8-10 donor beds at least one year before the headquarters move so our Mound Street donors become accustomed to the new location.

Conclude capital campaign for a new bloodmobile, putting the vehicle into service by the end of 2018. Because less than 4% of the population donates 100% of the blood supply, and LESS than 1%, 100% of the platelets, donating must be as convenient as possible.  That means taking its bloodmobiles to its donors  The average age of the fleet is 25 years and the last bloodmobile was purchased six years ago. Two had to be retired in the last few years due to their age. 

Increase our platelet donor base. Platelets will be vital as the SMH Cancer Treatment Center phases in its programs. Because the process takes up to two hours, the target audience is retirees.  SunCoast is developing a marketing and incentive program to reach and develop this demographic.

Needs Statement
  1. SunCoast must purchase a new bloodmobile in 2018. The cost is $199,625.00. This does not include the cost of the technology needed to equip the vehicle. It is approximately $60,000 from its goal.
  2. SunCoast must equip the new bloodmobile with four pieces of technology that range in price from $45,000 - $65,000 each.
  3. With the addition and expansion of programs at Sarasota Memorial Hospital, including the trauma center, and a cancer treatment center SunCoast must stay abreast of the community needs for blood products and the ability to house all of its operations. The board has voted to move the headquarters from its Mound Street location to a space and property better equipped to serve its needs.  This will likely require a capital campaign.
  4. The need to update technology is constant and expensive.  Blood banks are considered a pharmaceutical manufacturer and are highly regulated by the FDA. The FDA mandates certain upgrades and processes and the blood bank must keep up with their requirements. Therefore, once again, development is playing a greater role in the ability the purchase new technology that often exceeds our ability to pay. 
Background Statement

O.K. Fike and Dr. Millard White founded the Lower West Coast Blood Bank, now known as SunCoast Blood Bank, on February 14, 1949. They planted the seeds of a humanitarian idea that would blossom over six decades. Although the name has changed, the guiding principles of remaining an independent, local health-care provider, governed by a local board with local management has remained intact. For almost 70 years, tens of thousands of dedicated volunteers have provided the critical, life-saving gift of blood to our local hospitals and patients. In 1949 the Blood Bank collected 551 pints of blood, now called “units.” Today, SunCoast operates five donor centers, and more than 1,300 blood drives are held annually in our community. In FY 17-18 it must collect more than 40,000 units of blood products. The success of this organization rests completely on the generosity of volunteer donors.

For 69 years, SunCoast Blood Bank has been the sole provider of safe and reliable blood products and services to communities in Southwest Florida. SunCoast also provides transfusion services at several local hospitals. The most common need arises from cancer patients, trauma patients, and surgical patients.  The most vulnerable patients are newborns in crisis needing blood or platelets. SunCoast provides a wide range of blood services and medically-ordered therapeutic blood procedures to outpatients and inpatients throughout the region.  SunCoast Blood Bank provides 24/7 care 365 day of the year.
While the blood supply is the safest it has ever been, blood banks face a serious challenge - how to address the ever shrinking pool of eligible donors. This pool is dwindling at a staggering rate, while population and demand continue to grow. Only 38 percent of the US population is eligible to donate blood, and that percentage is likely to drop even more. Of those eligible to donate, less than 5% donate blood, and less than 1% donate platelets. The population of eligible blood donors is reduced, based on exclusions due to high-risk behaviors for transmitting infectious diseases, travel to areas with specific disease exposures, presence of chronic diseases, use of medications, and aging. The dramatic impact of these exclusions is intensified by the loss of the WWII generation. This "Greatest Generation,” those who established blood banks in the 1940’s, believed wholeheartedly in donating blood as a civic and patriotic duty. "Baby Boomers" are rapidly approaching the age at which they will require blood products, and their successors, the "Gen Xers," do not give as often as their parents and grandparents. New technologies cannot fully compensate for the diminishing numbers of donors. Cultivating the next generation of blood donors is the  challenge facing all blood banks. A great portion of the responsibility now falls to our youngest donors.  SunCoast has successfully cultivated a large donor group age 16-18 through its scholarship program. High school seniors who donate 3 times for more are eligible to apply.  To date, SunCoast has awarded more than $240,000 in scholarships. High school students now represent our largest donor group, supplying 25% of the local blood needs.
Blood drives are held at schools, businesses, community centers and places of worship seven days a week and account for 65% of all blood collection. By 2020 we expect that 70-80% of all blood products will be collected on bloodmobiles.
Areas Served
Areas Served
FL- Sarasota
FL- Manatee
FL- Charlotte
FL- DeSoto
Areas Served Comments
  • Sarasota - all zip codes
  • Bradenton
  • Lakewood Ranch
  • Arcadia
  • Englewood
  • North Port
  • Port Charlotte
  • Punta Gorda
  • Venice
  • Osprey
Service Categories
Primary Org Type Health Care
Secondary Org Type Medical Research
Tertiary Org Type Education
Statement from the Board Chair/Board President

I am proud to help lead the SunCoast Blood Bank in the performance of its vision and mission.   That is, to provide a reliable supply of quality blood products and services to hospitals and health centers in need not only here in our four-county area, but throughout the United States, in times of crisis.   Thanks to the support of local foundations, businesses, media, civic organizations, individual financial donors, and most of all, our loyal blood donors, SunCoast Blood Bank is stronger and more efficient and effective than ever. Thanks to the generosity of our community, we were able to replace our 10-year-old Blood Establishment Computer System last year, significantly contributing to the efficiency, reliability and safety of our product offerings.   It is a privilege to serve our community and contribute to its well-being.  Doing so is also a tremendous responsibility.  We must have the right blood products, of the highest quality, on the shelves of our client hospitals at the right time for patients in crisis.  As these demands increase, we must constantly assess and improve our ability to serve our clients by conducting thorough evaluations of our physical plant (bricks and mortar), technology systems, and equipment necessary to keep the blood supply safe and consistently available for the communities we serve.

Rear Admiral Steve Branham, USCG (retired) 

Statement from the CEO/Executive Director

SunCoast Blood Bank is a leader in blood banking and has been faithfully serving our community for the last 69 years. SunCoast has a life-saving mission that is focused on saving and enriching lives in our nregion. Our focus is to remain a local, independent blood center that builds symbiotic relationships with our blood donors and our patients. SunCoast provides high-quality blood products and transfusion services to our community hospitals and we also provide bedside cellular therapies for patients with rare blood disorders. SunCoast also engages in bio-collection research activities that range from helping to identify vaccines for breast cancer to improving equipment diagnostics. SunCoast is considered a leader in blood banking

SCBB is an innovative blood center that was the first entity to implement the INTERCEPT pathogen reduction technology in 2016. This revolutionary technology provides our hospitals with the safest platelet products in the world by inactivating viruses and bacteria including the Zika Virus, HIV, and Ebola.

In 2018, SCBB is also adding a state-of-the art FDA approved computer system that will add further safety measures to our operation and allow us to reduce costs by streamlining our processes and allowing us to go 100% paper-free.

With excellent management, superior technology and dedicated staff, another key to our success is a strong local presence. Unlike other mega blood centers, our structure is totally community based. As a CEO living in the community we serve, with a local board, I am able to move quickly and efficiently to serve the needs of the hospitals and health care providers we work with.

SCBB is grateful for the tremendous support it receives from our community. Our blood donors and our financial donors are the backbone of our organization. We strive each day to be the best, because lives depend on it.

Scott Bush, CEO


The Generation Give Scholarship Program was established in 2006. Studies show that students who begin donating in high school are likely to become life-long donors. The Generation Give program was established to motivate students to donate, thus beginning a life-long service to their community. The need for financial assistance to obtain the dream of a college education makes SunCoast's scholarship program a win-win situation. Students experience first-hand the opportunity to commit a life-saving act, and in turn they are eligible to receive a partial scholarship towards their post secondary tuition.
To be eligible, a student must donate blood or platelets three times during their senior year or demonstrate support of the SunCoast mission by volunteering at least 30 hours of service to SunCoast their senior year. Upon successfully completing these requirements, the student may apply for a scholarship, which if awarded, is paid directly to the college, technical school or university.
Budget $20,000
Category Education, General/Other Education, General/Other
Program Linked to Organizational Strategy Yes
Population Served Adolescents Only (13-19 years) Other Named Groups Other Named Groups
Short Term Success Many people cite the reason for not donating blood is fear of needles.  This is very common among teenagers.  Students who are motivated to continue their education, realize that every scholarship dollar matters.  SunCoast found that the prospect of receiving a scholarship was very appealing to high school seniors and the first year the program was offered, student donations increased approximately 10%.  As more students donated, they realized that it was a very easy and pain-free process. SunCoast staff worked with student leaders and taught them to recruit other students.  This peer-to-peer communication was very successful and as students were educated, more started to donate.

Long Term Success

Students now account for 25% of total blood donated in our community. As we face an on-going decrease in the population of adult donors, it is imperative that we continue reaching out to our youth to emphasize the importance of blood donation and the impact they are making in other people's lives by becoming a blood donor. This is the generation baby boomers and other populations will depend on as they age. 

National studies show that adolescents who donate blood at least three times are most likely to become life-long blood donors. Cultivating the next generation of blood donors is one step closer to assure that demand for blood will not exceed supply - an ongoing threat faced by all blood banks.

Program Success Monitoring

Community volunteers and SunCoast staff comprise a committee to establish guidelines and to review each scholarship application. As part of the application process, students are asked to evaluate several key areas that help SunCoast determine what best motivates students to become blood donors. The first year of the program, approximately 20 students applied for scholarships.  Last year, more than 60 submitted applications.  

With success comes disappointment.  It is not possible to fund each request and SunCoast is seeking a sponsorship so more funds can be awarded as the scholarship program grows in popularity. 
Program Success Examples
SunCoast has distributed over $240,00o in scholarships since the creation of the program. SunCoast maintains an extensive database that allows it to track donors. The data indicates that many of our young adult donors, began giving blood in high school.

A collaboration with Sarasota Memorial Hospital and Florida Cancer Specialists & Research Institute has enabled SunCoast Blood Bank to participate in groundbreaking cellular therapy (MNC) for patients undergoing prostate cancer treatments.

With the ovarian cancer therapy still in the clinical study phase, the prostate cancer program is FDA approved and currently active in many centers across the US.

MNC is an alternative treatment for stage-four prostate cancer patients which utilizes an individual’s own white blood cells to boost his own immune system. The therapy requires the extraction of dendritic cells which are sent to a lab for processing. These are then returned to be re-infused into the patient in the form of a vaccine designed to seek and attack prostate cancer cells. By stimulating the natural ability of immune cells already in the patient’s body, this therapy helps fight advanced prostate cancer and extends the life of the patient.
Budget $180,000
Category Medical Research, General/Other Cancer Research
Program Linked to Organizational Strategy Yes
Population Served Adults Males Adults
Short Term Success

MNC therapy is a rapidly growing and active field as more and more laboratories are finding ways to treat cancer.  Given the time required by each procedure and the regimen of treatments ordered for each patient, it is imperative that patients have access to a local provider of this service. Local patients undergoing prostate cancer treatment that require the MNC procedure no longer have to leave the comfort of their own community to receive care in larger centers.  With the expansion of our services to implement our own therapy center, patients have the option to be treated locally by an approved, regulated and suitably prepared institution. As our population ages, more men will be diagnosed with this common cancer.  SunCoast has the equipment, technology and space necessary to treat one patient at a time and anticipates needing to expand this treatment program in the near futures.

Long Term Success

Only licensed and properly equipped institutions can perform this procedure and SunCoast Blood Bank has the expertise and trained staff to offer this service to our community. MNC therapy is gaining momentum as a plan of treatment as more and more laboratories are finding ways to treat cancer.

Program Success Monitoring

Patients currently undergoing MNC therapy for stage-four prostate cancer are under the supervision of their local oncologist. SunCoast works closely with their medical providers during their treatment.

In a clinical trial that supported FDA approval, more men treated with MNC lived longer than men not using same procedure. More men in the same treatment group were alive 3 years after the start of the study than men not treated with the vaccine. The vaccine reduced the risk of death by 22.5% for patients in the treatment group and only 1.5% of men discontinued treatment due to side effects.

Program Success Examples

MNC is an immunotherapy of autologous dendritic cells re-infused into the patient consisting of prostatic acid phosphatase (PAP) linked to granulocyte-macrophage colony-stimulating factor. Sequential phase I and phase II trials were performed to determine the safety and efficacy of the vaccine and to assess its capacity to break. Reports from vaccine manufacturer shows that patients tolerated treatment well. Fever, the most common adverse event, occurred after 15 infusions (14.7%). All patients developed immune responses to the fusion protein used to prepare the vaccine, and 38% developed immune responses to PAP. Three patients had a more than 50% decline in prostate-specific antigen (PSA) level, and another three patients had 25% to 49% decreases in PSA. The time to disease progression correlated with development of an immune response to PAP and with the dose of dendritic cells received immune tolerance to the normal tissue antigen PAP. The first patient who received his therapy though SunCoast lived 1.5 years beyond his prognosis expectancy.  His wish was to live long enough to walk his engaged daughter down the aisle.  His wife called after he passed away to tell us he lived long enough to fulfill this wish and beyond.


SunCoast has taken steps to make the blood supply even safer by being the first blood bank in the country to acquire the INTERCEPT Blood System for platelets and plasma. This revolutionary technology significantly reduces the risk of transfusion-transmitted pathogens such as Zika, hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria, and dengue. Platelets are vital in the treatment of cancer patients, who are also the most vulnerable to fatal complications caused by pathogens. Platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will  dramatically improve patient outcomes in our community.

Cerus created a molecule called amotosalen which is filtered into the platelets and binds itself to DNA and RNA. The unit of platelets is then placed under a UV light which envelopes the pathogens which are then filtered out.

Budget $100,000
Category Health Care, General/Other Blood Banking
Program Linked to Organizational Strategy Yes
Population Served General/Unspecified People/Families of People with Cancer Aging, Elderly, Senior Citizens
Short Term Success
Because platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction dramatically reduces this possibility and improves patient outcomes in our community. An added benefit of the technology is that platelets can be released earlier after testing. Because they must be stored at room temperature, platelets are only good for five days. INTERCEPT can increase platelet effective shelf life by as much as half a day. This is significant since less than one percent of the population donates 100 percent of this vital blood product.
Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections, as we saw at some blood banks when the Zika virus emerged in Florida.
Long Term Success Currently the technology is only approved for platelets.  The blood banking industry is hopeful that the FDA will approve the technology for red cells.  This would enhance the safety of the blood supply on an entirely new level. It is anticipated that within the next few years, the FDA will mandate that all platelets be pathogen reduced.
Program Success Monitoring There has been a significant reduction in the number of bacteria-related complications from pathogen reduced platelets. 
Program Success Examples

The most relevant example is the use of the technology to combat the Ebola epidemic. Cerus was part of the team that went to West Africa as part of the Gates Foundation initiative to combat Ebola. Their INTERCEPT Blood System, was used to manufacture convalescent plasma to treat patients. The same technology was used for Ebola patients transferred to the United States for treatment.

When Zika became a threat to the continental US, pathogen reduced platelets were critical. 
Description Currently, platelet units can only be transfused up to 5 days after they are collected due to the fear of bacterial growth since all platelets must be stored at room temperature. The platelet dating program began in January, 2018. SunCoast is the first blood bank in Florida to use the Verax pan genera detection (PGD). With this technology SunCoast is able to perform a rapid secondary bacterial test on each platelet product prior transfusion to ensure that it is free from bacteria. This will add another safety layer to transfusion medicine in our community and also extends the life of the platelet product by up to another 48 hours.
Budget $20,000
Category Health Care, General/Other Blood Banking
Program Linked to Organizational Strategy Yes
Population Served People/Families of People with Health Conditions General/Unspecified
Short Term Success
Point of issue bacterial testing will have immediate benefits to the patient, the hospital, and the blood bank. 
Patient:  An added layer of protection to ensure that the platelet product that they are about to receive is free from any strain of bacteria. 
Hospital:  Reduces product wastage which lowers blood product costs for the hospital
SunCoast :  Platelets are very expensive to collect and challenging to manage so this program will help SunCoast to lower its platelet wastage by extending more time to these products that have such a short shelf-life
Long Term Success The long term success will be highly beneficial for SunCoast because it should cut the Platelet Outdate Rate in half, which should net the blood center over $200,000 annually.  Also, now that it can extend platelets for up to 7 days, it will mean that SunCoast will have more product available on its shelves for emergency purposes.   SunCoast will be able to track the success of this program with its transfusion usage data that is compiled and reviewed weekly.
Program Success Monitoring SunCoast will monitor and report its progress on the transfusion related outdate logs.  Its expectation is a sharp decrease in platelet outdates but it will also expect to see a positive financial impact on the balance sheet as the extra 2 days of product life will allow SunCoast to transfuse more units, which will benefit the organization's revenue.
Program Success Examples Since the program has only been in operation for a few weeks, it is too soon to provide complete data.  

Each year SunCoast selects a group of donors to recognize at a luncheon in their honor. It has recognized highest gallon donors, O negative (universal) donors, platelet donors etc. This year will focus on blood drive chairs. Approximately 65% of its blood products are collected at mobile drives and the success depends on the drive chair. This event gives the us the opportunity to thank these dedicated volunteers for the hours they spend organizing their drives and recruiting donors. Of equal importance the event will provide education for the drive chairs and update them on the work of SunCoast. We hope to motivate chairs to host additional drives during the year. An important item we cover is efficiency and reaching their goal to keep the cost of production as low as possible. We feel it is important to give these vital volunteers a "peak behind the curtain" to help them understand how important their role is to the overall success of the blood bank.

Budget $6,000
Category Health Care, General/Other Health Care, General/Other
Program Linked to Organizational Strategy Yes
Population Served People/Families of People with Health Conditions People/Families of People with Cancer
Short Term Success SunCoast has found that these recognition events inspire those who attend. The act of donating blood products is extremely selfless, as well as personal.  Donors are expected to divulge very private information about their lifestyle during the screening process and they are allowing the blood bank to literally extract tissue from their bodies.  It takes time (up to two hours to donate platelets) and dedication to be a donor.  The blood bank tracks the donation rate from the individuals who attend and it has found that up to 34% donate one additional time per year.
Long Term Success The most impact was demonstrated after the luncheon held in honor of its O neg donors.  This is the universal donor type which makes it critical when seconds matter.  Since anyone can receive O neg blood, in a health crisis when a transfusion must be immediate, the patient will receive O neg blood until their own blood can be typed and matched. While these events serve to honor donors, they also serve to educate.  Follow up after this luncheon indicated that five attendees referred other family members to become donors.  Approximately 21% made an additional donation during the year.  
Program Success Monitoring For one year following the event, donors who attend are tracked to determine if their donor pattern changes.
Program Success Examples At the O neg donor luncheon a trauma patient who received O negative blood described his accident.  All air emergency medical transports carry two units of O neg blood.  This patient was going into shock and was stabilized when transfused in flight.  His survival was credited to receiving those units of blood.  A flight nurse told about her experience at the scene of a high-speed motor vehicle crash.  In her situation, protocol dictated that flight personnel were not authorized to step in and aid ground EMT unless asked.  She said that she and her partner stood "on the sidelines" and knew that if they were not authorized to intervene, the crash victim was going to die.  They ran to their "rig" and got the blood and transfusion technology ready to go and as they were running back to the sideline the EMT gave them the signal to proceed.  They saved the victim's life and she told the audience that event changed her life forever.  Following the luncheon, two attendees drove directly to the blood bank to donate.
Program Comments by Organization
The biggest challenge continues to be containing the cost of collecting, testing, storing and transfusing blood products.  Hospitals are under pressure to keep the cost of healthcare in line and this filters down to the blood bank.  SunCoast has one of the leanest operations in the country due to its efficient operations and skilled staff. Most of the blood bank's associated technology is mandated by the FDA and is constantly evolving, improving and emerging.  SunCoast must rely on voluntary financial contributions to cover the cost of the technology required to keep the blood supply safe and available.
Another challenge continues to be the shrinking donor pool.  In order to attract and retain donors, SunCoast is streamlining its donor rewards program by partnering with local businesses to offer gift cards at a significant discount. Every third donation, the donor will earn a $20 gift card from a local business. Our business partners donate half of the gift cards. SunCoast has also increased its visibility by partnering with local media outlets.
Scott Bush, CEO 
CEO/Executive Director
CEO/Executive Director Mr. Scott M. Bush
CEO Term Start Aug 2011
CEO/Executive Director Email

Scott has over 25 years of experience in blood banking and joined SunCoast in 2005 as Director of Donor Services and Recruitment.   During his employment at SunCoast, Bush was recognized as a Top 40 Under 40 by the Gulf Coast Business Review in 2009 and also was awarded Executive of the Year by the Florida Association of Blood Banks in 2008. Prior to joining SCBB, Bush worked with the American Red Cross for 15 years overseeing various departments within their biomedical service operation.  Bush also served in the United States Naval Reserve where he received the Navy Medal of Achievement.

 In 2011, Bush was appointed CEO of SunCoast Blood Bank and sits on the Boards of Blood Centers of America (BCA) and Alliance for Community Transfusion Services (ACTS).   Over the last several years he has brought in new technologies and cellular therapies to provide the best possible care to those who need it in our community.
Scott is a graduate of Ohio Dominican University and earned his masters degree in non-profit management from University of Central Florida. He resides in Parrish with his 14 rescue animals. 
Former CEOs/Executive Directors
Mr. Kevin Lindberg Dec 2010 - Aug 2011
Dr. Mark J. Magenheim May 2003 - Dec 2010
Senior Staff
Mr. Mike Buell Director of Product Manufacturing
Mr. Christopher Ebert Information Technology Director
Mrs. Jayne Giroux Director of Community Development
Mr. John Hall Chief of Donor Operations
Mr. Robert Harper Director of Quality Assurance
Mrs. Karen Hoder Accounting Supervisor
Mr. Rei Lopez Chief of Laboratory Operations
Ms. Laura Williams Dircetor of Human Resources
Staff & Volunteer Statistics
Full Time Staff 87
Part Time Staff 42
Staff Retention Rate % 71
Professional Development Yes
Contractors 1
Volunteers 167
Management Reports to Board Yes
CEO/Executive Director Formal Evaluation Yes
Senior Management Formal Evaluation Yes
Non-Management Formal Evaluation Yes
  • Alliance for Community Transfusion Services
  • Blood Centers of America
  • Florida Cancer Specialists & Research Institute
  • Sarasota Memorial Hospital
  • Manasota Operation Troop Support
  • Manatee Memorial Hospital Foundation
  • Wildlife Rescue
  • Friendship Center
  • Cat Depot
  • Child Advocacy Center
  • Safe Place and Rape Crisis Center
  • Meals on Wheels
  • All Faiths Food Bank
  • Resurrection House
  • AARP, Senior Community Service Employment Program
  • Parrish United Methodist Church 
America Blood Centers2017
American Association of Blood Centers (AABB)2017
Englewood-Cape Haze Area Chamber of Commerce2017
Greater Sarasota Chamber of Commerce2017
Venice Area Chamber of Commerce2017
Charlotte County Chamber of Commerce2017
Manatee Chamber of Commerce2017
North Port Area Chamber of Commerce2017
US Food & Drug Administration (FDA)2017
External Assessments and Accreditations
AABB Donor Center Activities2016
AABB Transfusion Activities Accreditation2015
FDA Blood Bank Registration2015
Clinical Lab Improvement Amendments Accreditation2015
FDA Registration for Collection and Distribution2015
State of Florida Clinical Laboratory License2013
Awards & Recognition
Nonprofit of the YearSarasota Chamber of Commerce2017
Healthcare Organization of the YearSarasota Chamber of Commerce2015
Finalist - Champions of Healthcare AwardsManatee Chamber of Commerce2015
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2016
Corporate Partnership of the YearAmerica's Blood Centers2016
Most Creative Blood DriveAmerica's Blood Centers2016
Most Productive Blood DriveAmerica's Blood Centers2016
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2016
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2015
Terumo BCT Award of ExcellenceAmerica's Blood Centers2016
Outstanding Humanitarian Service AwardAmerica's Blood Centers2015
Blood Drive Achievement AwardAmerica's Blood Centers2016
ITxM AwardAmerica's Blood Centers2016
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2015
Innovation AwardFlorida Association of Blood Banks2015
Board Member of the Year - Mary Ann LeglerFlorida Association of Blood Banks2015
High School Achievement Award for Most Donations of Large-Sized Schools - Manatee High SchoolFlorida Association of Blood Banks2015
Hopsital Medical Professional Advocate of the Year AwardFlorida Association of Blood Banks2015
High School Achievement Award for Highest Participation of Large-Sized Schools - Manatee High SchoolFlorida Association of Blood Banks2015
Most Creative Donor Center AwardFlorida Association of Blood Banks2015
Media Partnership Service AwardFlorida Association of Blood Banks2015
7 Who Care Award of SupportWWSB ABC 72015
Dorothy C Smith R.N. Award - John HorneFlorida Association of Blood Banks2014
Hospital Partnership Award - Sarasota Memorial HospitalFlorida Association of Blood Banks2014
Donor Chairperson of the Year - Leslie CollierFlorida Association of Blood Banks2014
High School Achievement Award for Highest Participation of Mid-Sized Schools - Desoto High SchoolFlorida Association of Blood Banks2014
Most Creative Donor Center EventFlorida Association of Blood Banks2013
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2013
Media Partnership of the Year- WWSB ABC 7Florida Association of Blood Banks2013
Overall Most Productive Blood Drive - WSRZ 107.9Florida Association of Blood Banks2013
Media of the Year Award - WSRZ 107.9America's Blood Centers2012
The Most Creative Donor Center AwardFlorida Association of Blood Banks2012
Board Memeber of the Year - Maggie VeenemanFlorida Association of Blood Banks2012
High School Achievement Award for a Mid-Size School - Sarasota Military AcademyFlorida Association of Blood Banks2012
Risk Management Provisions
Automobile Insurance and Umbrella or Excess Insurance
Accident and Injury Coverage
Builders Risk
Commercial General Liability
Computer Equipment and Software
Disability Insurance
Employee Dishonesty
Fiduciary Liability
General Property Coverage
Life Insurance
Medical Health Insurance
Professional Liability
Workers Compensation and Employers' Liability
Automobile Insurance
Government Licenses
Organization Licensed by the Government Yes
Fundraising Plan Yes
Communication Plan Yes
Strategic Plan No
Strategic Plan Years
Strategic Plan Adopted 0
Management Succession Plan No
Continuity of Operations Plan No
Nondiscrimination Policy Yes
Whistle Blower Policy Yes
Document Destruction Policy Yes
Directors and Officers Insurance Policy Yes
Policies and Procedures Yes
Management Comments by Organization
SunCoast is fortunate to have a staff of dedicated professionals committed to our mission.  Each senior staff member plays a pivotal role in our organization and are experts in their respective fields.  Because of our leadership and customer-focused staff, SunCoast has emerged as a leader in the blood banking world and a model of efficiency for other blood banks across the United States. 
The blood bank saw many successes in FY 17-18: Named named Nonprofit of the Year by the Sarasota Chamber of Commerce; organized the Hurricance Harvey relief efforts, including using the resources of the US Navy, to provide hundreds of units of blood to the affected regions of Texas; worked with our community partners to ensure no patient waited for blood products when Hurricane Irma struck our community; and the first blood bank in the country to utilize Verax Biomedical technology to increase the life of platelets from five to seven days. In addition, for the last two years, SunCoast's independent auditors have praised its fiscal management, utilizing .92 cents of every dollar directly towards its mission. 
Due to our size and combined expertise, SunCoast will continue to embrace change and develop new strategies to further our its role within our community.  SunCoast has been called upon by centers and hospitals all around the country to assist them when they are in crisis and we have always been able to offer support in various levels of activities.  We are a gold-star blood center and pleased to provide these boutique services to our wonderful community.
Scott Bush, CEO 
Multi-Media Comments by Organization
SunCoast Blood Bank actively utilizes its media channels to fulfill the following needs:
  • Current blood product and type needs
  • Community awareness
  • Donor recruitment and retention
  • Donor communication
  • Fundraising
  • Promotions
  • Blood drives schedule and locations
  • Urgent and critcal shortage messaging
Other Documents
Other Document 2
Donor Recruitment
Board Chair
Board Chair Admiral, Ret. Steve Branham
Company Affiliation retired
Board Term Nov 2015 to Oct 2018
Board Chair Email
Board Members
Board Members
Admiral, Ret Steve Branham Retired
Mrs. Kathleen Hargreaves Kerkering Barberio
Mr. Ben Hatcher Capstan Financial Group
Mrs. Mary Ann Legler Manatee County School Board
Mr. Jeffery Reynolds Retired
Mrs. Kristine Russell Community Volunteer
Mr Ross Russo Swift Construction
Mr. Craig Tuley SunTrust
Mr. Juan Villavaces Attorney
Constituency Includes Client Representation No
Board Ethnicity
African American/Black 0
Asian American/Pacific Islander 0
Caucasian 8
Hispanic/Latino 1
Native American/American Indian 0
Other 0 0
Board Gender
Male 6
Female 3
Unspecified 0
Board Term Lengths 3
Board Term Limits 3
Board Orientation Yes
Number of Full Board Meetings Annually 11
Board Meeting Attendance % 78
Board Self-Evaluation Yes
Written Board Selection Criteria No
Board Conflict of Interest Policy Yes
% of Board Making Monetary Contributions 100
% of Board Making In-Kind Contributions 9
Standing Committees
Board Development / Board Orientation
Board Governance
Human Resources / Personnel
Strategic Planning / Strategic Direction
Development / Fund Development / Fund Raising / Grant Writing / Major Gifts
Governance Comments by Organization
Unlike large blood bank conglomerates, the SunCoast Board of Directors play a pivotal role in the direction of the organization.  Blood banking is a highly regulated, technical institution and it takes more time than is traditional for board members to feel comfortable in their decision-making role.  They must understand the legalistic, technological and the operational needs of the organization in order to make informed decisions about capital items as well as policies.  For this reason, term limits are longer than you might see with other nonprofits. 
Greater emphasis has been on fund development and the role of the board. Therefore, SunCoast now seeks board members with the willingness and aptitude to immerse themselves in this process. When new board members are vetted, the expectation of their participation is clearly spelled out.
Staff has worked closely with the board to establish realistic fundraising goals for which each board member is responsible.  As was suggested in the Fundraising Toolkit workshop facilitated by John Elbare, each board member completed a personal plan for fundraising. Members are given the option of raising funds through hard credits (writing a check) or soft credits (recruiting a financial donor, securing auction items etc.). Staff has created several avenues for board members to raise funds, to match to their comfort level. At the end of the fiscal year, individuals are given a report card to see where their contributions stand.  In addition, development is a prominent part of each board meeting.
A few members were apprehensive about their ability to meet their minimum giving requirements.  However, at the end of the year EACH member exceeded the minimum requirement. 
Scott Bush, CEO 
Fiscal Year Projections
Fiscal Year Start Month Oct
Fiscal Year Start Day 01
Fiscal Year Begins 2017
Fiscal Year End Month Sept
Fiscal Year End Day 30
Fiscal Year Ends 2018
Projected Revenue $14,075,301.00
Projected Expenses $13,845,042.00
Total Projected Revenue includes "in-kind" contributions/ donations Yes
Organization has Endowment No
Endowment Spending Policy N/A
Capital Campaign
Currently In a Capital Campaign Yes
Anticipate Campaign within 5 years? Yes
Campaign Purpose
Purchase a bloodmobile.
Campaign Goal $199,625.00
Campaign Dates Sept 2016 to May 2018
Amount Raised To Date 138787 as of Jan 2018
Historical Financial Review
Revenue SourcesHelpThe financial analysis involves a comparison of the IRS Form 990 and the audit report (when available) and revenue sources may not sum to total based on reconciliation differences. Revenue from foundations and corporations may include individual contributions when not itemized separately.
Fiscal Year201620152014
Foundation and
Corporation Contributions
Government Contributions$0$0$0
Individual Contributions$83,555$610,208$308,550
Investment Income, Net of Losses$99,301$77,073$50,951
Membership Dues$0$0$0
Special Events$71,740$44,416$26,551
Revenue In-Kind$190,769$288,877$271,468
Expense Allocation
Fiscal Year201620152014
Program Expense$11,521,054$12,030,095$12,594,549
Administration Expense$947,081$914,130$888,320
Fundraising Expense$134,787$162,199$75,437
Payments to Affiliates$0$0$0
Total Revenue/Total Expenses1.000.990.98
Program Expense/Total Expenses91%92%93%
Fundraising Expense/Contributed Revenue87%25%23%
Assets and Liabilities
Fiscal Year201620152014
Total Assets$9,539,000$8,885,068$9,210,723
Current Assets$5,933,673$4,845,258$5,200,979
Long-Term Liabilities$0$299,948$179,000
Current Liabilities$1,652,583$927,911$1,125,358
Total Net Assets$7,886,417$7,657,209$7,906,365
Top Funding Sources
Fiscal Year201620152014
Top Funding Source & Dollar AmountProcess and Service Fees $8,258,390Processing and Service Fees $8,098,868Processing and service fees $8,991,935
Second Highest Funding Source & Dollar AmountLaboratory Test Fees $2,322,403Laboratory Test Fees $2,102,696Lab Test Fees $1,978,295
Third Highest Funding Source & Dollar AmountExport Fees $988,707Export Fees $1,292,394Export Fees $1,162,404
CEO/Executive Director Compensation $175,001 - $200,000
Tax Credits No
Short Term Solvency
Fiscal Year201620152014
Current Ratio: Current Assets/Current Liabilities3.595.224.62
Long Term Solvency
Fiscal Year201620152014
Long-Term Liabilities/Total Assets0%3%2%
Financials Comments
Financial Comments by Organization

Though we recover the cost to collect, test, store, match and transfuse through fees charged for our products and services,we are not able to recover all of our costs due to the cut in reimbursement rates to the hospitals and our manufacturing costs.  As those reimbursement rates are cut, it indirectly effects our ability to fully cover our expense to procure, manufacture, test, store, and distribute just one safe pint of blood.  Furthermore, blood banks are one of the highest regulated nonprofit agencies in the US and often these regulations and federal mandates add further cost to our organization without way to recoup the fees needed to implement these new requirements.  Therefore, SunCoast had to diversify into other arenas such as cellular therapies, research and fundraising in order to continue its core mission within the community. 

One example is the emergence of Zika on our continent in 2016.  SunCoast knew it was inevitable that the FDA was going to mandate special testing for this disease due to its proliferation.  Adding a new testing protocol takes months to prepare and is an added testing expense.  Although blood banks can pass along the cost of required testing to its client hospitals, many hours of overtime are required to ensure that our collections would not be interrupted. As a result, SunCoast was prepared and implemented Zika testing one full week before the FDA mandated the test. Several blood banks in the state had to suspend collections in designated areas because they were not prepared. In those instances and only once local needs were met, SunCoast was able to assist some blood banks with needed units until their testing protocol was online.
We allocate a significant amount of funds toward capital improvements, however, the new technologies, tests, and equipment that are required often exceed our ability to pay.  Therefore, we rely on the generosity of foundations and individuals to help us remain operational as we strive to maintain a safe and reliable blood supply for our community. 

Scott Bush, CEO 

Financial Comments by Foundation
Financial figures taken from IRS Form 990 and audit documents.  990s and audits are reconciled for 2009 and 2010.  Total liabilities reported in 2008 audit: $776,879.  Individual contributions include foundation and corporate support, as reported on Form 990. In-kind contribution revenue includes non-cash contributions and donated services and use of facilities as reported on the IRS Form 990.  Donated services and facilities are not included in total revenue on the IRS Form 990. 
Nonprofit SunCoast Blood Bank
Address 1760 Mound St
Sarasota, FL 34236
Phone 941 954-1600 124